Cargando…

Correction to: Arsenic nano complex induced degradation of YAP sensitized ESCC cancer cells to radiation and chemotherapy

Detalles Bibliográficos
Autores principales:	Zhou, Wei, Liu, Meiyue, Li, Xia, Zhang, Peng, Li, Jiong, Zhao, Yue, Sun, Guogui, Mao, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816333/ https://www.ncbi.nlm.nih.gov/pubmed/33468231 http://dx.doi.org/10.1186/s13578-021-00535-2

Ejemplares similares

Arsenic nano complex induced degradation of YAP sensitized ESCC cancer cells to radiation and chemotherapy
por: Zhou, Wei, et al.
Publicado: (2020)

Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma
por: Zhu, Guanxia, et al.
Publicado: (2020)

Nicotine Activates YAP1 through nAChRs Mediated Signaling in Esophageal Squamous Cell Cancer (ESCC)
por: Zhao, Yue, et al.
Publicado: (2014)

Gambogic acid affects ESCC progression through regulation of PI3K/AKT/mTOR signal pathway
por: Yu, Jiarui, et al.
Publicado: (2020)

Correction to: KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription
por: Qin, Mei, et al.
Publicado: (2021)

NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143
por: Su, Wei, et al.
Publicado: (2022)

Correction to: Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
por: Lu, Yi-fang, et al.
Publicado: (2020)

Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
Publicado: (2014)

Efficacy and safety of camrelizumab in combination with neoadjuvant chemotherapy for ESCC and its impact on esophagectomy
por: Qiao, Yujin, et al.
Publicado: (2022)

Correction: Arsenic Trioxide Sensitizes Glioblastoma to a Myc Inhibitor
por: Yoshimura, Yayoi, et al.
Publicado: (2016)

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial: A randomized clinical trial of neoadjuvant therapy for ESCC
por: Li, Yong, et al.
Publicado: (2023)

Prognosis and Progression of ESCC Patients with Perineural Invasion
por: Xu, Guanghui, et al.
Publicado: (2017)

UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines
por: Palumbo, Antonio, et al.
Publicado: (2016)

MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6
por: Wei, Lei, et al.
Publicado: (2020)

Correction: YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2016)

Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
por: Wang, Kun, et al.
Publicado: (2023)

Correction to: Genetic diversity of arsenic accumulation in rice and QTL analysis of methylated arsenic in rice grains
por: Kuramata, Masato, et al.
Publicado: (2018)

NRIP3 upregulation confers resistance to chemoradiotherapy in ESCC via RTF2 removal by accelerating ubiquitination and degradation of RTF2
por: Suo, Daqin, et al.
Publicado: (2020)

Correction: YAP promotes tumorigenesis and cisplatin resistance in neuroblastoma
por: Yang, Chao, et al.
Publicado: (2022)

The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci
por: Zhou, Liqing, et al.
Publicado: (2015)

M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study
por: Wang, Shu, et al.
Publicado: (2023)

Correction: Lysogenic bacteriophages encoding arsenic resistance determinants promote bacterial community adaptation to arsenic toxicity
por: Tang, Xiang, et al.
Publicado: (2023)

Author Correction: ABHD5 inhibits YAP-induced c-Met overexpression and colon cancer cell stemness via suppressing YAP methylation
por: Gu, Yan, et al.
Publicado: (2023)

An Immune Cell-Based Signature Associating With EMT Phenotype Predicts Postoperative Overall Survival of ESCC
por: Yu, Hongliang, et al.
Publicado: (2021)

ATF3 suppresses ESCC via downregulation of ID1
por: Li, Jian, et al.
Publicado: (2016)

Correction: Bacterial community and arsenic functional genes diversity in arsenic contaminated soils from different geographic locations
por: Gu, Yunfu, et al.
Publicado: (2017)

Reply: Hookah, opium, and tobacco smoking in relation to ESCC
por: Malekzadeh, R, et al.
Publicado: (2009)

Correction to: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
por: Jin, Dan, et al.
Publicado: (2020)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)

Characterization of super‐enhancer‐associated functional lncRNAs acting as ceRNAs in ESCC
por: Wang, Qiu‐Yu, et al.
Publicado: (2020)

Correction: GATA2 Inhibition Sensitizes Acute Myeloid Leukemia Cells to Chemotherapy
por: Yang, Li, et al.
Publicado: (2017)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

Correction: m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
por: Jin, Dan, et al.
Publicado: (2022)

The Silencing of SFRP2 Expression in ESCC Is Due to Methylation of the Gene Promoter
por: Liu, Qian, et al.
Publicado: (2019)

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation
por: Khatri, Aaditya, et al.
Publicado: (2019)

Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent
por: Thakar, Manjusha, et al.
Publicado: (2020)

Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
por: Chen, Jie, et al.
Publicado: (2021)

Yes-Associated Protein (YAP) Modulates Oncogenic Features and Radiation Sensitivity in Endometrial Cancer
por: Tsujiura, Masahiro, et al.
Publicado: (2014)

Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
por: Wang, Yang, et al.
Publicado: (2013)

DEPDC1B collaborates with GABRD to regulate ESCC progression
por: Yuan, Yunfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffgs82r3ksn81dl4hlf4meqcjn